Παρασκευή 8 Ιανουαρίου 2016

Management of Immune Checkpoint Blockade Dysimmune Toxicities: a collaborative position paper

Based on Gustave Roussy immunotherapy clinical practice and experience in irAEs management together with our network of organs' specialists, we propose here some practical guidelines for the oncologist to help in the clinical care of patients under immune checkpoint blockade therapy.



from Cancer via ola Kala on Inoreader http://ift.tt/1UBSJAV
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου